Conservative manegement of a unicystic ameloblastoma

Abstract

Objective: To consider, through a case report, the benefits of choosing a conservative treatment in cases of unicystic ameloblastoma. Case report: This paper reports a unicystic ameloblastoma in a 20-year-old female patient who sought care 2 years after noticing the presence of the lesion. A conservative treatment protocol was performed, and after 1 year and 6 months of follow-up, a recurrence was found, which was removed by enucleation and curettage. Conclusion: Ameloblastoma is not a malignant tumor capable of metastasizing and should not be treated as such. The radical treatment of this pathology creates sequelae that make rehabilitation difficult. On the other hand, conservative treatment can be performed in an outpatient setting, bringing low functional, aesthetic and psychological impacts to the patient.